MedTrace Logo

Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

NCT04056104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 543

Last updated 2022-02-03

No results posted yet for this study

Summary

The purpose of this research is to evaluate and create a new clinical prediction model for CCHD screening that combines non-invasive measurements of oxygenation and perfusion.

Conditions

  • Congenital Heart Disease

Interventions

DIAGNOSTIC_TEST

SpO2 and PIx Measurement

Right upper and any lower extremity oxygen saturation (SpO2) and perfusion index (PIx) will be measured

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • University of California, Davis

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
21 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-23
Primary Completion
2021-12-12
Completion
2021-12-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04056104 on ClinicalTrials.gov